ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

An Alliance of NSABP-RTOG And GOG?

March 25, 2011

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

Feinstein Reintroduces New National Cancer Act

June 13, 2003

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

November 30, 1979